Is the business good?
How good a business is STAA?
STAAR Surgical Company earns −11% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
−11%
Return on invested capital · cost of capital 9.0% · 20 points below what the capital costs: growth destroys value
- Operating margin
- −9.1%
Operating margin · Medical Instruments & Supplies median 5.8% · 12 months to Q1 2026
- Share count, year on year
- +3.1%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 13%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2020 | 4.1% |
| FY2021 | 14% |
| FY2022 | 18% |
| FY2023 | 8.7% |
| FY2024 | −4.0% |
| FY2025 | −38% |
Details›
- Gross margin12 months to Q1 2026
- 77%
- Operating margin12 months to Q1 2026
- −9.1%
- Net margin12 months to Q1 2026
- −7.2%
- Free cash flow margin
- −19%
- R&D as % of revenue
- 13%
- Revenue, trailing twelve months
- $290M
- Free cash flow, trailing twelve months
- −$55M
- Net income, trailing twelve months
- −$21M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- −11%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Medical Instruments & Supplies
Ranks #1 of 27 by Smart Score